Lincoln Pharmaceuticals Limited

NSEI:LINCOLN 주식 보고서

시가총액: ₹13.6b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Lincoln Pharmaceuticals 배당금

배당금 기준 확인 5/6

Lincoln Pharmaceuticals 수익으로 충분히 충당되는 현재 수익률 0.23% 보유한 배당금 지급 회사입니다.

주요 정보

0.3%

배당 수익률

4%

지급 비율

업계 평균 수익률0.6%
다음 배당금 지급일n/a
전 배당일n/a
주당 배당금₹1.800
주당 순이익₹48.91
배당 수익률 예측n/a

최근 배당금 업데이트

Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be Increased To ₹1.80

Sep 08
Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be Increased To ₹1.80

Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Sep 14
Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50

Aug 31
Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50

Recent updates

Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be Increased To ₹1.80

Sep 08
Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be Increased To ₹1.80

Do Lincoln Pharmaceuticals' (NSE:LINCOLN) Earnings Warrant Your Attention?

Sep 06
Do Lincoln Pharmaceuticals' (NSE:LINCOLN) Earnings Warrant Your Attention?

Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Business And Shares Still Trailing The Market

Mar 14
Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Business And Shares Still Trailing The Market

Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?

Nov 04
Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?

Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Sep 14
Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50

Aug 31
Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50

Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Sep 12
Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Lincoln Pharmaceuticals (NSE:LINCOLN) Is Due To Pay A Dividend Of ₹1.50

Aug 29
Lincoln Pharmaceuticals (NSE:LINCOLN) Is Due To Pay A Dividend Of ₹1.50

If You Like EPS Growth Then Check Out Lincoln Pharmaceuticals (NSE:LINCOLN) Before It's Too Late

Feb 14
If You Like EPS Growth Then Check Out Lincoln Pharmaceuticals (NSE:LINCOLN) Before It's Too Late

Should You Be Adding Lincoln Pharmaceuticals (NSE:LINCOLN) To Your Watchlist Today?

Aug 16
Should You Be Adding Lincoln Pharmaceuticals (NSE:LINCOLN) To Your Watchlist Today?

Here's Why I Think Lincoln Pharmaceuticals (NSE:LINCOLN) Is An Interesting Stock

May 06
Here's Why I Think Lincoln Pharmaceuticals (NSE:LINCOLN) Is An Interesting Stock

Is Lincoln Pharmaceuticals Limited (NSE:LINCOLN) A Smart Choice For Dividend Investors?

Apr 03
Is Lincoln Pharmaceuticals Limited (NSE:LINCOLN) A Smart Choice For Dividend Investors?

Does Lincoln Pharmaceuticals (NSE:LINCOLN) Have A Healthy Balance Sheet?

Mar 15
Does Lincoln Pharmaceuticals (NSE:LINCOLN) Have A Healthy Balance Sheet?

Could The Market Be Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Given Its Attractive Financial Prospects?

Feb 28
Could The Market Be Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Given Its Attractive Financial Prospects?

Insider Buying: The Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Whole Time Director Just Bought 15% More Shares

Feb 12
Insider Buying: The Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Whole Time Director Just Bought 15% More Shares

Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?

Feb 01
Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?

Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 27% Gain In The Last Five Years

Jan 19
Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 27% Gain In The Last Five Years

Trade Alert: The Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Munjal Patel, Has Just Spent ₹20m Buying 9.2% More Shares

Jan 06
Trade Alert: The Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Munjal Patel, Has Just Spent ₹20m Buying 9.2% More Shares

Why Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Is A Dividend Rockstar

Dec 27
Why Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Is A Dividend Rockstar

Lincoln Pharmaceuticals's (NSE:LINCOLN) Earnings Are Growing But Is There More To The Story?

Dec 14
Lincoln Pharmaceuticals's (NSE:LINCOLN) Earnings Are Growing But Is There More To The Story?

Have Insiders Been Buying Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Shares This Year?

Dec 01
Have Insiders Been Buying Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Shares This Year?

Declining Stock and Solid Fundamentals: Is The Market Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN)?

Nov 18
Declining Stock and Solid Fundamentals: Is The Market Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN)?

Is Lincoln Pharmaceuticals (NSE:LINCOLN) A Risky Investment?

Nov 05
Is Lincoln Pharmaceuticals (NSE:LINCOLN) A Risky Investment?

결제의 안정성과 성장

배당금 데이터 가져오기

안정적인 배당: LINCOLN 의 주당 배당금은 지난 10 년 동안 안정적이었습니다.

배당금 증가: LINCOLN 의 배당금 지급은 지난 10 년 동안 증가했습니다.


시장 대비 배당 수익률

Lincoln Pharmaceuticals 시장 대비 배당 수익률
LINCOLN 배당 수익률은 시장과 어떻게 비교되나요?
세그먼트배당 수익률
회사 (LINCOLN)0.3%
시장 하위 25% (IN)0.2%
시장 상위 25% (IN)1.0%
업계 평균 (Pharmaceuticals)0.6%
애널리스트 예측 (LINCOLN) (최대 3년)n/a

주목할만한 배당금: LINCOLN 의 배당금( 0.24% )은 Indian 시장에서 배당금 지급자의 하위 25%( 0.24% )보다 높습니다. 0.24% ).

고배당: LINCOLN 의 배당금( 0.3% )은 Indian 시장에서 배당금 지급자의 상위 25% 1.12% ).


주주에 대한 수익 배당금

수익 보장: 낮은 지불 비율 ( 3.9% )로 인해 LINCOLN 의 배당금 지급은 철저히 수익으로 충당됩니다.


주주에 대한 현금 배당금

현금 흐름 범위: 현금 지급 비율 ( 15.3% )이 낮기 때문에 LINCOLN 의 배당금 지급은 현금 흐름으로 잘 충당됩니다.


강력한 배당금 지급 기업 알아보기